Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PBYI > SEC Filings for PBYI > Form 8-K on 4-Dec-2013All Recent SEC Filings

Show all filings for PUMA BIOTECHNOLOGY, INC.

Form 8-K for PUMA BIOTECHNOLOGY, INC.


4-Dec-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On December 4, 2013, Puma Biotechnology, Inc. (the "Company") issued a press release announcing the results from a Phase II clinical trial of the Company's investigational drug PB272 (neratinib) for the neoadjuvant treatment of breast cancer and scheduling a conference call to be held December 4, 2013 at 2:00 p.m. PST (5:00 p.m. EST) to discuss these trial results. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release dated December 4, 2013


  Add PBYI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PBYI - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.